Ultraviolet radiation-induced oxidative stress

Ultraviolet radiation-induced oxidative stress refers to the cascade of cellular events triggered when cells are exposed to ultraviolet light—primarily from solar sources. This exposure leads to increased production of reactive oxygen species through both direct photochemical reactions with cellular macromolecules and indirect mechanisms involving enzymes like catalase and nitric oxide synthase. The resulting imbalance between prooxidant forces and antioxidant defenses causes lipid peroxidation, DNA fragmentation, protein modification, apoptosis, immune modulation, impaired cell growth regulation, inflammation, carcinogenesis (especially skin cancer), ocular pathologies such as cataracts/macular degeneration, accelerated aging processes in tissues like skin/eye lens—and can overwhelm endogenous protective systems if unchecked. The generation of reactive oxygen species (ROS) by UV radiation is one mechanism through which UV light can manifest its possible detrimental effects on health. Oxidative stress can lead to cellular damage, apoptosis and cell death. UVR absorbed from solar radiation can induce extensive skin damage through mechanisms ranging from direct DNA damage to those resulting from the formation of platelet activating factor and mitochondrial dysfunction. While some pharmacologic agents can mitigate downstream effects by scavenging ROS or blocking secondary mediators like platelet activating factor receptors, there is no single druggable molecular target corresponding specifically to “ultraviolet radiation-induced oxidative stress.” Instead, therapeutic strategies focus on prevention/protection—such as sunscreen use—or on modulating antioxidant capacity. In summary: Ultraviolet radiation-induced oxidative stress should not be considered an individual therapeutic target but rather an important pathogenic mechanism underlying several diseases associated with sun/UV exposure.

Other names

UVR-induced oxidative stressUV-induced ROS generationUltraviolet light–induced ROS production

Drugs used in this context act by scavenging reactive oxygen species (e.g., antioxidants) or by inhibiting downstream mediators like PAF-R antagonists to prevent immune suppression and cancer progression after UV exposure.